Skip to main content
. 2023 Apr 14;14:1131662. doi: 10.3389/fmicb.2023.1131662

Figure 2.

Figure 2

Case study 1: Microbial diversity (A,B), cell counts (cells/mL) (C) and average microbial composition at family level (cells/mL) (D) of the in vivo-derived inocula (INO) and upon 24 h of incubation in the SIFR® technology in absence of prebiotic treatment (NSC) (n = 6).